MeSH tree: C16.320.365.826
A new study of UCLA Health's large genetic biobank is giving researchers new insights into the disease risks faced by the region's diverse communities and their access to health care. The effort, published in Nature Medicine, ...
Jul 18, 2023
0
61
Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease (SCD) and beta thalassemia. These two common life-threatening anemias afflict millions of individuals across the globe.
Jun 29, 2023
0
46
Human volunteers have received the first-ever transfusion of lab grown red blood cells in a groundbreaking scientific first. Volunteers received about 5ml-10ml of blood (around 1-2 teaspoons), which contained around 15 billion ...
Dec 13, 2022
0
42
If you follow health trends online, you might have heard about "chlorophyll water." Claims range from clearing your skin, stopping body odor, increasing energy and oxygen, to detoxing your liver and preventing cancer.
Nov 30, 2022
0
31
Scientists at St. Jude Children's Research Hospital have shown how a protein responsible for adapting to low oxygen conditions (hypoxia), causes increased expression of fetal hemoglobin (HbF) in adults. The finding has implications ...
Oct 12, 2022
0
61
Bluebird Bio Inc.'s gene therapy for a brain-wasting disease received accelerated approval from U.S. regulators, making it the first treatment of its kind for children living with cerebral adrenoleukodystrophy.
Sep 19, 2022
0
47
The U.S. Food and Drug Administration has approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood ...
Aug 23, 2022
0
42
